Andrew C. von Eschenbach, MD

In his role as Senior Advisor, Dr. von Eschenbach provides strategic counsel on regulatory and public affairs, clinical trial development, and other critical corporate matters.

Dr. von Eschenbach is widely recognized as a leading physician, surgeon, oncologist, and executive. His distinguished career includes serving as Commissioner of the FDA from 2006 to 2009, after being appointed Acting Commissioner in 2005.  In that role, he developed and oversaw the FDA’s Critical Path Initiative which aimed at improving the regulatory pathway for drugs and medical devices. Dr. von Eschenbach joined FDA after serving for four years as Director of the National Cancer Institute at the National Institutes of Health, and currently serves on the Board of Directors of the Reagan-Udall Foundation for the FDA.

Dr. von Eschenbach earned a B.S. from St. Joseph’s University and his medical degree from Georgetown University School of Medicine. He served as Lt. Commander in the U.S. Navy Medical Corps. After completing residency in urologic surgery at Pennsylvania Hospital in Philadelphia, he completed a fellowship in urologic oncology at the University of Texas M.D. Anderson Cancer Center.